In breast cancer cell lines, CD24 expression reduces stromal cell-derived factor-1-mediated migration and signalling via CXCR4, suppressing their metastatic potential, whilst CD24−/low cells have conversely been shown to increase metastatic potential [171]. This evidence concerns the gene CD24 and breast carcinoma.